Reference Source

Pelikon Investments Limited · 66-41 · CYPRUS

For Pelikon Investments Limited · 66-41 · CYPRUS, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is CYPRUS; product is Abarelix; product code is 60 V - - 99 Anterior Pituitary Suppressor N.E.C. | 64 R - - 21 Somatropin (Hormone) | 64 X - - 11 Isotretinoin (Keratolytic); date published is 07/30/2019; address is Peter Kraus, Mykinon , Nicosia No. 1065, CYPRUS, verified against its source on 2026-09-16.

Firm
Pelikon Investments Limited verified
Import alert
66-41
Import alert name
Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
Country
CYPRUS verified
Address
Peter Kraus, Mykinon , Nicosia No. 1065, CYPRUS verified
Date published
07/30/2019 verified
Product code
60 V - - 99 Anterior Pituitary Suppressor N.E.C. | 64 R - - 21 Somatropin (Hormone) | 64 X - - 11 Isotretinoin (Keratolytic) each item verified
Product
Abarelix verified
Sourceaccessdata.fda.gov
Verified
Review by
DatasetFDA import alert red lists: firms subject to detention without physical examination

What the source says

Pelikon Investments Limited Date Published : 07/30/2019 Peter Kraus, Mykinon , Nicosia No. 1065, CYPRUS 60 V - - 99 Anterior Pituitary Suppressor N.E.C. Date Published: 07/30/2019 Desc: Abarelix Notes: 64 R - - 21 Somatropin (Hormone) Date Published: 10/07/2020 Notes: 64 X - - 11 Isotretinoin (Keratolytic) Date Published: 10/07/2020 Notes:

accessdata.fda.gov, retrieved 2026-09-15

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.

This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.